FARMAC
0472.489.968 · rovalta.com · 08/11/2026
FARMAC
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOFARMAC is a Private limited company incorporated in 2000. Its main activity is: Electrical installation. Its registered office is in Peer. It employs on average 49,0 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0472.489.968
- Incorporation
- 28/07/2000
- Legal form
- Private limited company
- Registered office
- Nijverheidsstraat 6
3990 Peer · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 49,0 ETP
Joint committees (3)
- 149
- 14901
- 200
Financials
Source · NBB, 20 filingsTrend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 4,4 M € | +10.3% | 4 M € | +10.1% | 3,6 M € | +3.9% | 3,5 M € | -7.4% | 3,7 M € |
| EBITDA | 1,1 M € | -8.8% | 1,2 M € | +22.2% | 965 k € | +5.9% | 911,6 k € | -32.4% | 1,3 M € |
| Operating result | 534 k € | -23.9% | 701,3 k € | +30.7% | 536,4 k € | +0.2% | 535,4 k € | -48.4% | 1 M € |
| Net result | 306,1 k € | -27.4% | 421,5 k € | +26.0% | 334,5 k € | -11.3% | 377,1 k € | -51.7% | 780,8 k € |
| Balance sheet | |||||||||
| Equity | 2,2 M € | +6.2% | 2 M € | +13.5% | 1,8 M € | +9.4% | 1,6 M € | +13.7% | 1,4 M € |
| Total assets | 5,7 M € | +7.1% | 5,3 M € | +9.2% | 4,9 M € | +19.4% | 4,1 M € | +29.1% | 3,1 M € |
| Cash | 127,7 k € | -83.0% | 751,7 k € | +44.4% | 520,7 k € | +93.6% | 268,9 k € | -61.1% | 691,5 k € |
| Debts | 3,5 M € | +7.6% | 3,3 M € | +6.6% | 3,1 M € | +26.2% | 2,4 M € | +42.1% | 1,7 M € |
| Other | |||||||||
| Workforce | 49,0 ETP | +3.6% | 47,3 ETP | +4.4% | 45,3 ETP | 0.0% | 45,3 ETP | 0.0% | 45,3 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20252 active · 2 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 31/07/2025 | |||
| Directorsince 31/07/2025 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director29/04/2016 → 2024 accountsManager29/04/2016 → 2020 accounts |
Other companies at this address
Nijverheidsstraat 6 3990 Peer| Company | CBE no. |
|---|---|
AT PROJECTONTWIKKELING● Active | 1042.384.764 |
BG PARTNERS● Active | 1025.157.168 |
GETHIJ● Active | 0758.911.172 |
KIRT● Active | 1024.799.159 |
MILAX● Active | 0651.955.311 |
PWR2● Active | 1033.255.777 |
Tijdelijke Maatschap FARMAC-APK● Active | 1011.514.020 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 02/07/2026 | 23/06/2025 | 24/06/2024 | 19/07/2023 | 07/07/2022 | 06/07/2021 |
| General meeting | 19/06/2026 | 20/06/2025 | 21/06/2024 | 28/04/2023 | 25/04/2022 | 24/04/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 19/06/2026 | 02/07/2026 | Dutch | |
| Abridged model | 31/12/2024 | 20/06/2025 | 23/06/2025 | Dutch | |
| Abridged model | 31/12/2023 | 21/06/2024 | 24/06/2024 | Dutch | |
| Abridged model | 31/12/2022 | 28/04/2023 | 19/07/2023 | Dutch | |
| Abridged model | 31/12/2021 | 25/04/2022 | 07/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 24/04/2021 | 06/07/2021 | Dutch | |
| Abridged model | 31/12/2019 | 24/04/2020 | 26/06/2020 | Dutch | |
| Abridged model | 31/12/2018 | 24/04/2019 | 09/07/2019 | Dutch | |
| Abridged model | 31/12/2017 | 24/04/2018 | 27/06/2018 | Dutch | |
| Abridged model | 31/12/2016 | 24/04/2017 | 07/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 29/04/2016 | 26/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 28/04/2015 | 26/06/2015 | Dutch | |
| Abridged model | 31/12/2013 | 28/04/2014 | 29/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 29/04/2013 | 30/07/2013 | Dutch | |
| Abridged model | 31/12/2011 | 28/04/2012 | 25/06/2012 | Dutch | |
| Abridged model | 31/12/2010 | 28/04/2011 | 28/06/2011 | Dutch | |
| Abridged model | 31/12/2009 | 28/04/2010 | 19/07/2010 | Dutch | |
| Abridged model | 31/12/2008 | 23/03/2009 | 30/06/2009 | Dutch | |
| Abridged model | 31/12/2007 | 28/04/2008 | 27/06/2008 | Dutch | |
| Abridged model | 31/12/2006 | 28/04/2007 | 03/07/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active · 2 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 31/07/2025 | |||
| Directorsince 31/07/2025 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director29/04/2016 → 2024 accountsManager29/04/2016 → 2020 accounts |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates20/08/2025ONTSLAGEN - BENOEMINGEN
- Other27/08/2021STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ALGEMENE VERGADERING
- Mandates27/06/2016ONTSLAGEN - BENOEMINGEN
- Registered office29/08/2012MAATSCHAPPELIJKE ZETEL
- Mandates15/04/2008ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Nijverheidsstraat 6, 3990 PeerCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00242165 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| FARMACCurrent | accounts 2006 → 2025 | Accounts 2025 · 2026-00242165 |
Events
- 2025Annual accounts 2025306,1 k €↓
- 2024Annual accounts 2024421,5 k €↑
- 2023Annual accounts 2023334,5 k €↓
- 2022Annual accounts 2022377,1 k €↓
- 2021Annual accounts 2021780,8 k €↑
- 2020Annual accounts 2020588,4 k €↑
- 2019Annual accounts 2019362,1 k €↓
- 2018Annual accounts 2018411,1 k €↑
- 2017Annual accounts 2017253 k €↑
- 2016Annual accounts 2016120,3 k €↓
- 2015Annual accounts 2015413,8 k €↑
- 2014Annual accounts 2014202,2 k €↓
- 2013Annual accounts 2013204,8 k €↑
- 2012Annual accounts 2012160,7 k €↓
- 2011Annual accounts 2011192,8 k €↑
- 2010Annual accounts 201069,8 k €↓
- 2009Annual accounts 2009159,6 k €↓
- 2008Annual accounts 2008217,5 k €↑
- 2007Annual accounts 2007109,8 k €↑
- 2006Annual accounts 200689,8 k €
- 28/07/2000IncorporationPrivate limited company